Jay S. Stout

CIK: 0001702969

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)24 (92.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (7.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

IMVT

Immunovant, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (26 total)

IMVT
Immunovant, Inc.
Oct 21, 2026
Sale(S)
Direct
2.6K shares at avg. $28.94$75K
IMVT
Immunovant, Inc.
Oct 7, 2026
Sale(S)
Direct
2.2K shares at avg. $32.06$71K
IMVT
Immunovant, Inc.
Oct 7, 2026
Sale(S)
Direct
1.6K shares at avg. $32.06$51K
IMVT
Immunovant, Inc.
Jul 23, 2026
Sale(S)
Direct
2.9K shares at avg. $38.69$111K
IMVT
Immunovant, Inc.
Jul 8, 2026
Sale(S)
Direct
77 shares at avg. $39.99$3K
IMVT
Immunovant, Inc.
Jul 8, 2026
Sale(S)
Direct
105 shares at avg. $39.99$4K
IMVT
Immunovant, Inc.
Jul 8, 2026
Sale(S)
Direct
1.4K shares at avg. $39.53$55K
IMVT
Immunovant, Inc.
Jul 8, 2026
Sale(S)
Direct
1.9K shares at avg. $39.53$75K
IMVT
Immunovant, Inc.
Jun 26, 2026
Sale(S)
Direct
6.7K shares at avg. $38.94$262K
IMVT
Immunovant, Inc.
Jun 26, 2026
Sale(S)
Direct
33.3K shares at avg. $38.18$1.3M
IMVT
Immunovant, Inc.
Apr 23, 2026
Sale(S)
Direct
2.8K shares at avg. $29.62$82K
IMVT
Immunovant, Inc.
Apr 8, 2026
Sale(S)
Direct
8.6K shares at avg. $24.83$214K
IMVT
Immunovant, Inc.
Apr 8, 2026
Sale(S)
Direct
1.5K shares at avg. $24.83$38K
IMVT
Immunovant, Inc.
Apr 7, 2026
Award(A)
Direct
66.9K shares-
IMVT
Immunovant, Inc.
Jan 21, 2026
Sale(S)
Direct
2K shares at avg. $26.03$51K
IMVT
Immunovant, Inc.
Jan 7, 2026
Sale(S)
Direct
1.1K shares at avg. $26.51$30K
IMVT
Immunovant, Inc.
Jan 7, 2026
Sale(S)
Direct
55 shares at avg. $26.92$1K
IMVT
Immunovant, Inc.
Oct 22, 2025
Sale(S)
Direct
2.5K shares at avg. $19.03$48K
IMVT
Immunovant, Inc.
Oct 8, 2025
Sale(S)
Direct
1.6K shares at avg. $16.30$26K
IMVT
Immunovant, Inc.
Jul 23, 2025
Sale(S)
Direct
2.8K shares at avg. $18.15$51K
IMVT
Immunovant, Inc.
Jul 9, 2025
Sale(S)
Direct
1.5K shares at avg. $17.24$26K
IMVT
Immunovant, Inc.
Apr 23, 2025
Sale(S)
Direct
1.9K shares at avg. $14.79$28K
IMVT
Immunovant, Inc.
Apr 9, 2025
Sale(S)
Direct
5K shares at avg. $12.99$65K
IMVT
Immunovant, Inc.
Apr 1, 2025
Award(A)
Direct
76.2K shares-
IMVT
Immunovant, Inc.
Jan 22, 2025
Sale(S)
Direct
2.2K shares at avg. $23.59$52K

		Type	Shares	Price		Ownership
Oct 21, 2026	IMVT Immunovant, Inc.	Sale(S)	2,595	$28.94	$75,099	Direct
Oct 7, 2026	IMVT Immunovant, Inc.	Sale(S)	2,213	$32.06	$70,949	Direct
Oct 7, 2026	IMVT Immunovant, Inc.	Sale(S)	1,596	$32.06	$51,168	Direct
Jul 23, 2026	IMVT Immunovant, Inc.	Sale(S)	2,857	$38.69	$110,537	Direct
Jul 8, 2026	IMVT Immunovant, Inc.	Sale(S)	77	$39.99	$3,079	Direct
Jul 8, 2026	IMVT Immunovant, Inc.	Sale(S)	105	$39.99	$4,199	Direct
Jul 8, 2026	IMVT Immunovant, Inc.	Sale(S)	1,399	$39.53	$55,302	Direct
Jul 8, 2026	IMVT Immunovant, Inc.	Sale(S)	1,906	$39.53	$75,344	Direct
Jun 26, 2026	IMVT Immunovant, Inc.	Sale(S)	6,723	$38.94	$261,794	Direct
Jun 26, 2026	IMVT Immunovant, Inc.	Sale(S)	33,277	$38.18	$1,270,516	Direct
Apr 23, 2026	IMVT Immunovant, Inc.	Sale(S)	2,754	$29.62	$81,573	Direct
Apr 8, 2026	IMVT Immunovant, Inc.	Sale(S)	8,614	$24.83	$213,886	Direct
Apr 8, 2026	IMVT Immunovant, Inc.	Sale(S)	1,518	$24.83	$37,692	Direct
Apr 7, 2026	IMVT Immunovant, Inc.	Award(A)	66,937	-	$0	Direct
Jan 21, 2026	IMVT Immunovant, Inc.	Sale(S)	1,977	$26.03	$51,461	Direct
Jan 7, 2026	IMVT Immunovant, Inc.	Sale(S)	1,148	$26.51	$30,433	Direct
Jan 7, 2026	IMVT Immunovant, Inc.	Sale(S)	55	$26.92	$1,481	Direct
Oct 22, 2025	IMVT Immunovant, Inc.	Sale(S)	2,520	$19.03	$47,956	Direct
Oct 8, 2025	IMVT Immunovant, Inc.	Sale(S)	1,585	$16.30	$25,836	Direct
Jul 23, 2025	IMVT Immunovant, Inc.	Sale(S)	2,805	$18.15	$50,911	Direct
Jul 9, 2025	IMVT Immunovant, Inc.	Sale(S)	1,519	$17.24	$26,188	Direct
Apr 23, 2025	IMVT Immunovant, Inc.	Sale(S)	1,925	$14.79	$28,471	Direct
Apr 9, 2025	IMVT Immunovant, Inc.	Sale(S)	5,004	$12.99	$65,002	Direct
Apr 1, 2025	IMVT Immunovant, Inc.	Award(A)	76,181	-	-	Direct
Jan 22, 2025	IMVT Immunovant, Inc.	Sale(S)	2,195	$23.59	$51,780	Direct

1-25 of 26 transactions

About Stout Jay S

Stout Jay S (SEC CIK 0001702969) files insider reports with the SEC as Chief Technology Officer of Immunovant, Inc. (IMVT).

Signal8 holds 19 ownership filings by Stout Jay S, all Form 4s, filed between Oct 25, 2024 and Oct 23, 2026. Those filings report 26 transactions, from Oct 23, 2024 to Oct 21, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Stout Jay S's filings is in DURHAM, NC.

Recent filings by Stout Jay S

Oct 21, 2026: Open-market sale of IMVT shares (Form 4, code S).
Oct 7, 2026: Open-market sales of IMVT shares (2 lines, Form 4, code S).
Jul 23, 2026: Open-market sale of IMVT shares (Form 4, code S).
Jul 8, 2026: Open-market sales of IMVT shares (4 lines, Form 4, code S).
Jun 26, 2026: Open-market sales of IMVT shares (2 lines, Form 4, code S).

Other insiders filing for Immunovant, Inc. (IMVT)

Girao Tiago, Chief Financial Officer
Van Tuyl Christopher, Chief Legal Officer
Gloria Melanie, Chief Operating Officer
Venker Eric, Chief Executive Officer
Pande Atul, Director
Fromkin Andrew J., Director

How to read Form 4 transaction codes